Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
03/22/2012 | WO2012037543A1 Host supported genetic biosensors |
03/22/2012 | WO2012037413A2 Systems and methods for biotransformation of carbon dioxide into higher carbon compounds |
03/22/2012 | WO2012037324A2 Increasing carbon flow for polyhydroxybutyrate production in biomass crops |
03/22/2012 | WO2012037254A1 MODIFIED iRNA AGENTS |
03/22/2012 | WO2012037123A1 Microbes, methods, and devices for redox-imbalanced metabolism |
03/22/2012 | WO2012037107A1 Compositions and methods for xylem-specific expression in plant cells |
03/22/2012 | WO2012036993A1 Computationally optimized broadly reactive antigens for influenza |
03/22/2012 | WO2012036884A2 Bioproduction of aromatic chemicals from lignin-derived compounds |
03/22/2012 | WO2012036507A2 Aptazyme specifically releasing antisense against microrna in hcv-infected cells, and use thereof |
03/22/2012 | WO2012036437A2 Immunogenic peptide and composition having the peptide for preventing or treating hpv-related disease |
03/22/2012 | WO2012036410A2 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same |
03/22/2012 | WO2012036392A2 Human anti-epidermal growth factor receptor fab antibody and a pharmaceutical composition for treating tumours comprising the same |
03/22/2012 | WO2012036391A2 Surface expression vector of porcine circovirus type 2 (pcv2) gene and salmonella vaccine strain transformed with same |
03/22/2012 | WO2012036350A1 Method for detecting target mrna of synthesized micro-rna |
03/22/2012 | WO2012036329A1 Composition or kit for making a prognosis of liver cancer, and method for making a prognosis of liver cancer |
03/22/2012 | WO2012036302A1 Process for producing vinylglycine derivatives |
03/22/2012 | WO2012036301A1 Process for producing vinylglycine derivatives |
03/22/2012 | WO2012036290A1 Method for cultivating lilies containing delphinin in the petals thereof |
03/22/2012 | WO2012036259A1 Model animal for studying hair growth cycle |
03/22/2012 | WO2012036241A1 Novel extracellularly secreted nuclease |
03/22/2012 | WO2012036215A1 Inhibitor of hmgb protein-mediated immune response activation, and screening method |
03/22/2012 | WO2012036211A1 Skin activation by means of pdgf-bb activity enhancement |
03/22/2012 | WO2012036151A1 Sulfur amino acid-producing bacteria and method for producing sulfur amino acids |
03/22/2012 | WO2012036111A1 Primer, probe, and method for multi-specimen analysis |
03/22/2012 | WO2012035115A1 A raft deficient yeast expression system for the production of recombinant membrane proteins |
03/22/2012 | WO2012035088A1 Na+/Mg2+ exchanger |
03/22/2012 | WO2012035066A1 Hot1 and uses thereof |
03/22/2012 | WO2012035050A2 Factor viii variants having a decreased cellular uptake |
03/22/2012 | WO2012035034A1 Serpin-finger fusion polypeptide |
03/22/2012 | WO2012034969A1 Gt aptamer oligonucleotides and use thereof as antitumor agents |
03/22/2012 | WO2012034942A1 Compounds for the modulation of aurora kinase b expression |
03/22/2012 | WO2012034865A1 Methods for increasing the size of plants or plant organs |
03/22/2012 | WO2012034532A1 Hereditary spinocerebellar ataxia-related gene and use thereof |
03/22/2012 | WO2012034197A1 Synthetic gene for expressing sm-14 in pichia pastoris, methods for producing and purifying sm-14 and the use thereof as a vaccine and diagnostic medium |
03/22/2012 | WO2012013823A3 A yeast artificial chromosome carrying the mammalian glycosylation pathway |
03/22/2012 | WO2012007965A8 Enzyme for the production of optically pure 3 - quinuclidinol |
03/22/2012 | WO2011153440A3 Transposon mutagenesis system and methods of use |
03/22/2012 | WO2011153323A3 Compositions and methods directed to treating liver fibrosis |
03/22/2012 | WO2011145915A3 Modified polyhedrin, and polyhedras and biotechnological products obtained from same |
03/22/2012 | WO2011139846A3 Compositions and methods for reduced scarring and for treatment of fibrosis |
03/22/2012 | WO2011120474A9 Method for inhibiting hiv replication in mammal and human cells |
03/22/2012 | WO2011116088A9 Compositions and methods for the detection of genomic features |
03/22/2012 | WO2011112845A3 Methods and compositions related to a multi-methylation assay to predict patient outcome |
03/22/2012 | WO2005032457A3 Vectors and methods for immunization against norwalk virus using transgenic plants |
03/22/2012 | US20120073019 Yield Enhancement in Plants by Modulation of a ZM-CIPK1 Protein |
03/22/2012 | US20120073018 Jatropha curcas curcin genes, tissue-specific promoters and generation of curcin-deficient transgenic jatropha plants |
03/22/2012 | US20120073017 Method for producing chrysanthemum plant having petals containing modified anthocyanin |
03/22/2012 | US20120073016 Axmi-150 delta-endotoxin gene and methods for its use |
03/22/2012 | US20120073015 Methods for plant transformation using spectinomycin selection |
03/22/2012 | US20120073014 Zantedeschia Variety 110167-55633 |
03/22/2012 | US20120073013 Lettuce variety paulita (ls9498) |
03/22/2012 | US20120073012 Lettuce variety carini (ls9499) |
03/22/2012 | US20120073002 Prevention and treatment of blood coagulation-related disases |
03/22/2012 | US20120073001 Methods and compositions for treating or preventing pruritis |
03/22/2012 | US20120072120 Automatic threshold setting and baseline determination for real-time pcr |
03/22/2012 | US20120071859 Inducible interleukin-12 |
03/22/2012 | US20120071645 Tetrahydropyran nucleic acid analogs |
03/22/2012 | US20120071631 Isolation and Characterization of Novel Green Fluorescent Proteins from Copepods |
03/22/2012 | US20120071546 Novel Glutamic Acid Decarboxylase (GAD) Chimera And Methods Of Use |
03/22/2012 | US20120071545 Compositions and methods for treatment of bacterial and mycobacterial infections |
03/22/2012 | US20120071436 Method, composition and kit for antigenic binding of norwalk-like viruses |
03/22/2012 | US20120071419 Target-Specific Non-Antibody Protein and Method for Preparing the Same |
03/22/2012 | US20120071415 Dominant negative mutants of sam68 for use in the treatment of spinal muscular atrophy (sma) |
03/22/2012 | US20120071395 TREATMENT OF MAMMALIAN PHYSIOLOGICAL REACTION OF IgE ANTIBODIES PRESENT IN SAID MAMMAL UPON CONTACT WITH THE CORRESPONDEING ANTIGEN |
03/22/2012 | US20120071394 Novel polypeptides and use thereof |
03/22/2012 | US20120071361 Substrate Preparation Process |
03/22/2012 | US20120071348 Methods for large scale functional evaluation of nucleotide sequences in plants |
03/22/2012 | US20120071344 Compositions and methods for identifying enzyme and transport protein inhibitors |
03/22/2012 | US20120070900 T-dna/protein nano-complexes for plant transformation |
03/22/2012 | US20120070899 Effective vector platform for gene transfer and gene therapy |
03/22/2012 | US20120070894 Thermophilic and thermoacidophilic sugar transporter genes and enzymes from alicyclobacillus acidocaldarius and related organisms, methods |
03/22/2012 | US20120070893 Methods for producing nonadherent avian cell lines |
03/22/2012 | US20120070892 DNA Virus MicroRNA and Methods for Inhibiting Same |
03/22/2012 | US20120070891 Inhibition-based high-throughput screen strategy for cell clones |
03/22/2012 | US20120070890 Targeted gene modification by parvoviral vectors |
03/22/2012 | US20120070881 Bacillus licheniformis chromosome |
03/22/2012 | US20120070876 Variant form of urate oxidase and use thereof |
03/22/2012 | US20120070871 Polypeptide having d-lactate dehydrogenase activity, polynucleotide encoding the polypeptide, and process for production of d-lactic acid |
03/22/2012 | US20120070868 Production of odd chain fatty acid derivatives in recombinant microbial cells |
03/22/2012 | US20120070863 Novel beta-galactoside-alpha2,3-sialyltransferase, a gene encoding thereof, and a method for producing thereof |
03/22/2012 | US20120070826 Lafora's disease gene |
03/22/2012 | US20120070824 Thermostable proteinases from thermophilic bacteria |
03/22/2012 | US20120070819 Determination of Interactions of Constant Parts of Antibodies with FC-Gamma Receptors |
03/22/2012 | US20120070486 Methods and compositions related to prefoldin and its regulation |
03/22/2012 | US20120070460 Dendritic cell modulatory molecule |
03/22/2012 | US20120070456 Polypeptide carrier protein |
03/22/2012 | US20120070454 Dengue vaccine, pharmaceutical composition comprising the same, nucleotide sequence and antibody composition |
03/22/2012 | US20120070447 Methods of administering / dosing anti-rsv antibodies for prophylaxis and treatment |
03/22/2012 | US20120070446 Rsv specific binding molecule |
03/22/2012 | US20120070439 Antigen-binding proteins |
03/22/2012 | US20120070437 Method of identifying compounds that bind baff-r |
03/22/2012 | US20120070436 Antigen-binding proteins |
03/22/2012 | US20120070435 Chimeric antigens for eliciting an immune response |
03/22/2012 | US20120070419 Method of altering the differentiative state of a cell and compositions thereof |
03/22/2012 | DE19735587B4 Peptid mit radioprotektiver Wirkung, dieses enthaltende kosmetische oder pharmazeutische Zusammensetzung, für dieses kodierende Nukleinsäure, Herstellungsverfahren für dieses Peptid und die Verwendung als radioprotektives Agens Peptide having radioprotective effect, cosmetic or pharmaceutical composition containing it, for this coding nucleic acid, production processes for this peptide and use as radioprotektives agent |
03/22/2012 | DE102007020302B4 Verbesserte dreidimensionale biokompatible Gerüststruktur, die Nanopartikel beinhaltet Improved three-dimensional biocompatible scaffold structure, the nanoparticles includes |
03/22/2012 | CA2848656A1 Systems and methods of delivery of bioactive agents using bacterial toxin-derived transport sequences |
03/22/2012 | CA2812046A1 Modified irna agents |
03/22/2012 | CA2811538A1 Na+/mg2+ exchanger |
03/22/2012 | CA2811501A1 Inhibitor of hmgb protein-mediated immune response activation, and screening method |